STOCK TITAN

McKesson - MCK STOCK NEWS

Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.

McKesson Corporation (symbol: MCK) is a leading healthcare services and information technology company, dedicated to improving the business of healthcare globally. Ranked 11th on the Fortune 500 list, McKesson collaborates with a diverse range of stakeholders including payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and other entities across the healthcare spectrum. The company's mission is to foster healthier organizations that deliver superior care to patients in every setting.

McKesson is one of the top three pharmaceutical wholesalers in the United States, engaging in the sourcing and distribution of branded, generic, and specialty pharmaceutical products. Their extensive client base includes retail chains, independent pharmacies, mail-order pharmacies, hospital networks, and healthcare providers. Alongside Cencora and Cardinal Health, McKesson commands over 90% of the US pharmaceutical wholesale industry.

Beyond the US, McKesson's reach extends to Canada, where they are involved in pharmaceutical wholesale and distribution. Additionally, McKesson supplies medical-surgical products and equipment to healthcare facilities and offers a range of technology solutions tailored for pharmacies.

McKesson's comprehensive service offerings include pharmaceutical and medical-surgical supply management, healthcare information technology solutions, and business and clinical services. The company is committed to helping its customers enhance their financial, operational, and clinical performance, ultimately aiming to deliver better patient care.

Recent achievements include strategic partnerships and innovative projects that continue to position McKesson as a key player in the healthcare industry. Their ongoing projects are designed to streamline operations and improve efficiency across the board, ensuring that healthcare providers can focus on patient care.

For more details on McKesson Corporation, visit www.mckesson.com.

Rhea-AI Summary

McKesson (NYSE: MCK) has released its fiscal 2025 first quarter financial results, which are now available on the company's Investor Relations website. McKesson will host a live webcast of the earnings conference call for investors on Wednesday, August 7th at 4:30 PM ET to review these results. The audio webcast, earnings press release, financial tables, and slide presentation will be accessible on McKesson's Investor Relations website. This platform also provides information about upcoming events for the investor community.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.34%
Tags
-
Rhea-AI Summary

McKesson (NYSE:MCK) has announced a 15% increase in its quarterly dividend to $0.71 per share, up from $0.62 in the previous quarter. The dividend will be payable on October 1, 2024, to stockholders of record on September 2, 2024. This marks McKesson's eighth consecutive annual dividend increase, reflecting the company's confidence in its business fundamentals and financial strength. CEO Brian Tyler emphasized McKesson's commitment to a disciplined capital deployment strategy, focusing on growth and shareholder value creation. The dividend hike underscores the company's strong balance sheet and robust free cash flow generation capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.96%
Tags
dividends
-
Rhea-AI Summary

McKesson (NYSE: MCK) is set to release its first quarter fiscal 2025 financial results on August 7, 2024, after market close. A live webcast of the earnings conference call will be held at 4:30 PM Eastern Time, available on McKesson’s Investor Relations website. The webcast will cover financial results, including earnings release, financial tables, and a slide presentation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
Rhea-AI Summary

McKesson announced the election of Dr. Deborah Dunsire to its board of directors, effective June 3, 2024. Dr. Dunsire, with over 30 years of experience in the biopharmaceutical and oncology sectors, will also serve on the Compensation and Talent Committee and Finance Committee. She recently retired as CEO of H. Lundbeck A/S and has held leadership roles at XTuit Pharmaceuticals, FORUM Pharmaceuticals, and Millennium: The Takeda Oncology Company.

Meanwhile, current board members Linda Mantia and Susan Salka will not stand for re-election at the 2024 Annual Meeting of Shareholders. The board size will reduce to 11 members, 10 of whom will be independent. McKesson's board chair, Donald Knauss, expressed gratitude for their contributions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.63%
Tags
management
-
Rhea-AI Summary

McKesson (NYSE: MCK) has reported its fiscal 2024 fourth quarter financial results. The earnings conference call for investors will be held today, May 7th. The company's financial results, along with a slide presentation, can be accessed on McKesson's Investor Relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.39%
Tags
-
Rhea-AI Summary
McKesson (NYSE:MCK) announces a quarterly dividend of 62 cents per share of common stock, payable on July 1, 2024, to stockholders of record on June 3, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.64%
Tags
dividends
Rhea-AI Summary
McKesson (MCK) is set to announce its fourth quarter and full year fiscal 2024 financial results on May 7, 2024. Investors can join the live webcast at 4:30 PM Eastern Time to review the company's performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.45%
Tags
-
Rhea-AI Summary
McKesson Corporation (MCK) has released its fiscal 2024 third-quarter financial results. The company will host a live webcast of the earnings conference call for investors on February 7th at 4:30 PM ET to review its financial results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.4%
Tags
-
Rhea-AI Summary
McKesson Corporation (MCK) declared a regular dividend of 62 cents per share of common stock, payable on April 1, 2024, to stockholders of record on March 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.39%
Tags
dividends
Rhea-AI Summary
McKesson Corporation (MCK) adds new director and announces the acquisition of Compile, a healthcare data platform, at the 42nd Annual J.P. Morgan Healthcare Conference. Kevin Ozan joins the board of directors, increasing the number to 12. Ozan, a former executive at McDonald's, brings extensive leadership experience in strategy and finance. The acquisition of Compile is expected to enhance McKesson's commercial data platform and provide insights to biopharma customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
conferences

FAQ

What is the current stock price of McKesson (MCK)?

The current stock price of McKesson (MCK) is $597.71 as of February 21, 2025.

What is the market cap of McKesson (MCK)?

The market cap of McKesson (MCK) is approximately 75.6B.

What services does McKesson Corporation provide?

McKesson provides pharmaceutical and medical-surgical supply management, healthcare information technology solutions, and business and clinical services.

Where does McKesson Corporation operate?

McKesson operates primarily in the United States and Canada, supplying pharmaceutical and medical-surgical products and providing healthcare IT solutions.

Who are McKesson's primary clients?

McKesson's clients include payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and other healthcare providers.

What makes McKesson a leading pharmaceutical wholesaler?

McKesson's significant market share, along with its partnerships with Cencora and Cardinal Health, allows it to command over 90% of the US pharmaceutical wholesale industry.

How does McKesson help improve healthcare delivery?

McKesson enhances healthcare delivery by providing products and technology solutions that improve the financial, operational, and clinical performance of healthcare providers.

What are some recent achievements of McKesson Corporation?

Recent achievements include strategic partnerships and innovative projects aimed at streamlining operations and improving efficiency in healthcare delivery.

Can individuals buy products directly from McKesson?

McKesson primarily serves healthcare providers and does not sell products directly to individual consumers.

How does McKesson contribute to the healthcare industry?

McKesson contributes by ensuring efficient distribution of pharmaceuticals, providing essential medical-surgical products, and offering technology solutions for better healthcare management.

What is the significance of McKesson's partnerships?

McKesson's partnerships allow the company to expand its reach, improve service delivery, and ensure better patient care across various healthcare settings.

Where can I find more information about McKesson Corporation?

For more information, visit McKesson's official website at www.mckesson.com.
McKesson

NYSE:MCK

MCK Rankings

MCK Stock Data

75.64B
124.94M
0.1%
88.89%
1.26%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
IRVING